DE1412520U - - Google Patents

Info

Publication number
DE1412520U
DE1412520U DENDAT1412520D DE1412520DU DE1412520U DE 1412520 U DE1412520 U DE 1412520U DE NDAT1412520 D DENDAT1412520 D DE NDAT1412520D DE 1412520D U DE1412520D U DE 1412520DU DE 1412520 U DE1412520 U DE 1412520U
Authority
DE
Germany
Prior art keywords
security
bolt
die
steering
ttift
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1412520D
Other languages
German (de)
English (en)
Publication of DE1412520U publication Critical patent/DE1412520U/de
Active legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
DENDAT1412520D Active DE1412520U (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
DE1412520U true DE1412520U (cg-RX-API-DMAC7.html)

Family

ID=722878

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1412520D Active DE1412520U (cg-RX-API-DMAC7.html)

Country Status (1)

Country Link
DE (1) DE1412520U (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
DE1412520U (cg-RX-API-DMAC7.html)
US8003785B2 (en) Halo-substituted pyrimidodiazepines
Guyenet et al. Role of excitatory amino acids in rat vagal and sympathetic baroreflexes
Witty et al. Effects of papaverine and hemorrhage on renin secretion in the nonfiltering kidney
DE2415082C3 (de) 1 -{Cumaran-5-yl-methyl)-piperazine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2345064B2 (de) 4-Amino-2-(U3,4-tetrahydroisochinolin-2-yl)-chinazolinderivate and diese enthaltende Arzneimittel
Robertson et al. Chronic hypotension: in the shadow of hypertension
DD155991A5 (de) Verfahren zur herstellung von imidazolin-derivaten
Brody et al. Role of central catecholaminergic systems in pathogenesis and treatment of hypertension
Kent et al. Odorant-specific spatial patterns in mucosal activity predict perceptual differences among odorants
Waleszczyk et al. Motion sensitivity in cat's superior colliculus: contribution of different visual processing channels to response properties of collicular neurons
Lokhandwala et al. Cardiovascular pharmacology of adrenergic and dopaminergic receptors: therapeutic significance in congestive heart failure
Tung et al. Hypertensive effect of yohimbine following selective injection into the nucleus tractus solitarii of normotensive rats
HSU et al. Xylazine‐induced mydriasis in rats and its antagonism by α‐adrenergic blocking agents
Rundqvist et al. Rapid fall in sympathetic nerve hyperactivity in patients with heart failure after cardiac transplantation
Calabrese Adrenergic receptors: biphasic dose responses
AU2009331990B2 (en) Novel polymorphic forms of 6-(1-methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2H-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof
DE1443013U (cg-RX-API-DMAC7.html)
WO1997040020A1 (de) Phthalazinderivate, deren herstellung und verwendung als arzneimittel
BENNETT INTEROCEPTIVE DISCRIMINATIVE STIMULI PRODUCED BY CLONIDINE: RELATIONSHIP TO ALPHA (2) ADRENORECEPTOR STIMULATION AND HYPOTENSION
EP0078989B1 (de) Pyridazinonimine und ihre physiologisch verträglichen Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende therapeutische Mittel
DE1359675U (cg-RX-API-DMAC7.html)
Paciorek et al. The α2-adrenoceptor selectivities and haemodynamic effects of WY26392 and yohimbine in the anaesthetised dog
Zubari Iraq: US seeks Cooperation in Rebuilding Iraq Iraq: September 2-October 15: US Campaigns for International Legitimacy; Kofi Annan Questions US Pre-emption Policy; David Kay submits Report on Iraq WMD
DE1429006U (cg-RX-API-DMAC7.html)